Save Inbrija for "Off" Episodes of Parkinson's Despite Optimized Meds

May 2019

Inbrija (in-BREE-jah) will be the first INHALED levodopa for adults with Parkinson's disease.

Think of Inbrija as a fast-acting levodopa...it starts to work in about 10 minutes and lasts about an hour. It joins the only other "on demand" option...Apokyn (apomorphine), a subcutaneous injection.

Inbrija is used as needed to treat "off" episodes...when scheduled carbidopa/levodopa wears off between doses and symptoms (rigidity, tremor, etc) return, especially as Parkinson's progresses.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

12 issues every year, with brief articles about new meds and guidelines
48+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Aspirin Be Ready With Answers About Aspirin for CV Disease Prevention
Depression Save Spravato as a Last-Line Option for Resistant Depression
Antithrombotics Balance Risks and Benefits of Antithrombotic Combos in Atrial Fib
Dermatology Prepare Patients for Actinic Keratosis Treatment
Parkinson's Disease Save Inbrija for "Off" Episodes of Parkinson's Despite Optimized Meds
Beta-Blockers Don't Shy Away From Selective Beta-Blockers in Most COPD or Asthma Patients
Ophthalmology Lean Away From Cequa for Dry Eyes
Establish Boundaries for Prescribing Meds for Yourself or Family
Infectious Diseases Be Prepared to Manage Osteomyelitis Patients on Oral Antibiotics
ADHD Put Psychosis Risk for ADHD Stimulants in Perspective
Women's Health Expect Limited Use of IV Brexanolone (Zulresso) for Postpartum Depression

Save Inbrija for "Off" Episodes of Parkinson's Despite Optimized Meds

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Table of Contents